SCHEMBL6581028

SCHEMBL6581028

COC(=O)c1ccc(OC(F)F)c(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.50
LMNA P02545 2/20 0.50
MAPK1 P28482 1/20 0.50
RAB9A P51151 1/20 0.50
MAPT P10636 2/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
XDH P47989 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
TAS1R3 Q7RTX0 1/20 0.45
TAS1R1 Q7RTX1 1/20 0.45
NOTUM Q6P988 2/20 0.44
KMT2A Q03164 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31475537 1.00 HTT (0.50) HTTLMNAMAPK1RAB9AMAPT
SCHEMBL22980803 0.87 NOTUM (0.48) HTTMAPTCA12CA1CA2
SCHEMBL2586590 0.87 KCNQ3 (0.54) HTTLMNAMAPK1RAB9AMAPT
SCHEMBL2910822 0.84 CA12 (0.59) HTTLMNAMAPTCA12CA1
SCHEMBL22954276 0.84 MAPT (0.64) HTTLMNAMAPK1RAB9AMAPT
SCHEMBL3738587 0.84 MAPT (0.64) HTTLMNAMAPK1RAB9AMAPT
SCHEMBL29723267 0.84 CA12 (0.59) HTTLMNAMAPTCA12CA1
SCHEMBL2279735 0.83 HTT (0.49) HTTLMNAMAPK1RAB9AMAPT
SCHEMBL30108554 0.83 HTT (0.49) HTTLMNAMAPK1RAB9AMAPT
SCHEMBL1988161 0.83 HTT (0.71) HTTLMNAMAPK1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed
EP-1070708-B1 Triazole derivatives HOFFMANN LA ROCHE (CH) 2004-01-14 EP disclosed
US-6265426-B1 CENTRAL NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. 2001-07-24 US disclosed
EP-1070708-A1 Triazole and imidazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2001-01-24 EP disclosed